[340 Pages Report] The global non-hyaluronic acid dermal filler market size is expected to reach US$ 520.4 Million by 2032. As per FMI Analysts, the global non-hyaluronic acid dermal filler market is estimated to be valued at US$ 392.7 Million in 2022 and is projected to increase at a CAGR of 2.6% from 2022 to 2032.
| Report Attribute | Details |
|---|---|
| Non-Hyaluronic Acid Dermal Filler Market Estimated Base Year Value (2021) | US$ 382.75 Million |
| Non-Hyaluronic Acid Dermal Filler Market Expected Market Value (2022) | US$ 392.7 Million |
| Non-Hyaluronic Acid Dermal Filler Market Anticipated Forecast Value (2032) | US$ 520.4 Million |
| Non-Hyaluronic Acid Dermal Filler Market Projected Growth Rate (2022 to 2032) | 2.6% CAGR |
In recent years, cosmetic plastic surgery has become more popular as it helps to restore a youthful appearance, which includes both surgical and nonsurgical procedures that enhance and reshape structures of the body to improve appearance and confidence.
The market has introduced several advanced aesthetic procedures that are non-invasive or minimally invasive to achieve a youthful appearance for the face and neck area. They include non-hyaluronic acid dermal fillers that are used to retain skin elasticity and maintain a youthful appearance.
The new generation of fillers performs a stimulatory effect, inducing collagen fibers in a focal area of the face, which increases the volume. They are composed of calcium hydroxylapatite, polyalkylimide, polylactic acid, and polymethyl-methacrylate microspheres (PMMA).
Among the primary factors driving the demand for non-hyaluronic acid dermal fillers are the increasing demand for surgical-medical cosmetic procedures, changing demand patterns for less painful treatments among consumers, and increased availability of non-hyaluronic acid dermal fillers by the market share leader.
Increasing advertising in glossy magazines and hoardings by leading manufacturers and distributors will raise public awareness of aesthetic products, thereby helping the market for non-hyaluronic acid dermal fillers to grow.
It is important to note that the primary factors hampering the growth of non-hyaluronic acid dermal fillers market are incorrect training of professionals as well as the high cost of physician services for a procedure. Furthermore, reimbursement options for minimally invasive treatments and procedures are unavailable, which also hampers the growth of the non-hyaluronic acid dermal fillers market.
Regional and local market players are forming strategic partnerships with international players in key target countries such as Japan, South Korea, Thailand, Singapore, and UAE to enhance sales of non-hyaluronic acid dermal filler and collaborating with leading international players in key target countries such as Japan, South Korea, Thailand, Singapore, and UAE to advance commercial presence.
Because less hyaluronic acid is used in non-hyaluronic-based dermal fillers, North America dominates the non-hyaluronic acid dermal fillers market with a 49.2% share.
An IDE clinical trial conducted by Silk Medical Aesthetics and Evolved by Nature for its all-natural dermal filler for nasolabial folds (NLFs) demonstrated positive results in November 2021 with 44 patients.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The non-hyaluronic acid dermal filler market has received a lot of traction in the industry.
Increasing demand for surgical and medical cosmetic procedures, changing consumer preferences for less painful treatments, the preference of dermatologists for non-surgical treatments, and increased offerings for non-hyaluronic acid dermal fillers by the market leader are all factors driving demand for non-hyaluronic acid dermal fillers.
It is anticipated that greater advertising will be done in glossy magazines and hoardings by top manufacturers and distributors, encouraging people to become aware of aesthetic products and ultimately boosting the market for non-hyaluronic acid dermal fillers.
Nonetheless, improper training of professionals for non-hyaluronic acid dermal filler procedures and high physician services costs are factors inhibiting the growth of non-hyaluronic acid dermal fillers. In addition, reimbursement options are missing for minimally invasive treatments and procedures, which further hampers demand for non-hyaluronic acid dermal fillers.
The market size of non-hyaluronic acid dermal fillers is classified geographically into seven key regions, including North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan, the Middle East, and Africa.
In North America, non-hyaluronic acid dermal fillers hold a 49.2% market value share because of increasing procedures associated with non-hyaluronic-based dermal fillers.
With continuous product launches by regional players, Western Europe is expected to account for the second-largest market value share at 22.8%.
Due to medical tourism for aesthetic procedures in ASEAN countries, APEJ can be seen as the fastest-growing region in terms of demand for non-hyaluronic acid dermal fillers, while MEA and Latin America hold the smallest market share by value due to shortages of skilled professionals.
Principal Consultant
A successful FDA approval for Galderma's Restylane Kysse was received in May 2020. The product is approved for adults over 21 with indications of lip enhancement and correction of upper perioral rhytides (wrinkles around the top of the lips).
It was announced in November 2021 that Silk Medical Aesthetics and Evolved by Nature had completed a feasibility study for their all-natural dermal filler for nasolabial folds (NLFs) that had received FDA approval under the Investigational Device Exemption (IDE).
Some of the leading companies operating in the global non-hyaluronic acid dermal filler market include Allergan, Inc. Galderma SA, Merz Pharma GmbH & Co. KGaA, Suneva Medical Inc., Specialty European Pharma, Sinclair Pharma, Valeant Pharmaceuticals International Inc., LifeCell Corporation, Dr. Korman Laboratories Ltd., ForeverInject International Holdings Co. Limited.
For the promotion and marketing of non-hyaluronic acid dermal fillers, leading manufacturers are focusing on co-promotions and co-marketing strategies, forming strategic partnerships with international players in key target countries like Japan, South Korea, Thailand, Singapore, and UAE, and forming expansionary distribution agreements with dermatologists.
An FDA-approved Investigational Device Exemption (IDE) clinical trial of Silk Medical Aesthetics' all-natural dermal filler for nasolabial folds (NLFs) was conducted in November 2021 with Silver Medical Aesthetics and Evolved by Nature.
The U.S Food and Drug Administration approved Restylane Kysse by Galderma in May 2020, indicated for lip augmentation and to lessen upper perioral rhytides (wrinkles around the lips).
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 2.6% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global non-hyaluronic acid dermal filler market is set to exceed US$ 139.4 Million by 2032.
The U.S. is projected to lead the non-hyaluronic acid dermal filler market in the forecast period.
The non-hyaluronic acid dermal filler market is likely to secure a CAGR of 2.6% through 2032.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Non-Hyaluronic Acid Dermal Filler Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Non-Hyaluronic Acid Dermal Filler Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032
5.3.1. Collagen
5.3.2. Hydroxylapatite
5.3.3. Polylactic Acid
5.3.4. Polyalkylimide
5.3.5. Polymethyl-Methacrylate Microspheres
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032
6. Global Non-Hyaluronic Acid Dermal Filler Market Analysis 2017-2021 and Forecast 2022-2032, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032
6.3.1. Aesthetic Volume Restoration
6.3.2. Wrinkle Reduction
6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
6.5. Absolute $ Opportunity Analysis By Application, 2022-2032
7. Global Non-Hyaluronic Acid Dermal Filler Market Analysis 2017-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Non-Hyaluronic Acid Dermal Filler Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Product Type
8.2.3. By Application
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By Application
8.4. Key Takeaways
9. Latin America Non-Hyaluronic Acid Dermal Filler Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Product Type
9.2.3. By Application
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Application
9.4. Key Takeaways
10. Europe Non-Hyaluronic Acid Dermal Filler Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Product Type
10.2.3. By Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Application
10.4. Key Takeaways
11. Asia Pacific Non-Hyaluronic Acid Dermal Filler Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. Malaysia
11.2.1.5. Singapore
11.2.1.6. Australia
11.2.1.7. Rest of Asia Pacific
11.2.2. By Product Type
11.2.3. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Application
11.4. Key Takeaways
12. MEA Non-Hyaluronic Acid Dermal Filler Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of MEA
12.2.2. By Product Type
12.2.3. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Application
12.4. Key Takeaways
13. Key Countries Non-Hyaluronic Acid Dermal Filler Market Analysis
13.1. U.K.
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Product Type
13.1.2.2. By Application
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Product Type
13.2.2.2. By Application
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Product Type
13.3.2.2. By Application
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Product Type
13.4.2.2. By Application
13.5. Rest of Latin America
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Product Type
13.5.2.2. By Application
13.6. Germany
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Product Type
13.6.2.2. By Application
13.7. U.K.
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Product Type
13.7.2.2. By Application
13.8. France
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Product Type
13.8.2.2. By Application
13.9. Spain
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Product Type
13.9.2.2. By Application
13.10. Italy
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Product Type
13.10.2.2. By Application
13.11. Rest of Europe
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Product Type
13.11.2.2. By Application
13.12. China
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Product Type
13.12.2.2. By Application
13.13. Japan
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Product Type
13.13.2.2. By Application
13.14. South Korea
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Product Type
13.14.2.2. By Application
13.15. Malaysia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Product Type
13.15.2.2. By Application
13.16. Singapore
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Product Type
13.16.2.2. By Application
13.17. Australia
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2021
13.17.2.1. By Product Type
13.17.2.2. By Application
13.18. Rest of Asia Pacific
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2021
13.18.2.1. By Product Type
13.18.2.2. By Application
13.19. GCC Countries
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2021
13.19.2.1. By Product Type
13.19.2.2. By Application
13.20. South Africa
13.20.1. Pricing Analysis
13.20.2. Market Share Analysis, 2021
13.20.2.1. By Product Type
13.20.2.2. By Application
13.21. Israel
13.21.1. Pricing Analysis
13.21.2. Market Share Analysis, 2021
13.21.2.1. By Product Type
13.21.2.2. By Application
13.22. Rest of MEA
13.22.1. Pricing Analysis
13.22.2. Market Share Analysis, 2021
13.22.2.1. By Product Type
13.22.2.2. By Application
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Product Type
14.3.3. By Application
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Allergan, Inc.
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. Galderma SA
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. Merz Pharma GmbH & Co.
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. KGaA
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. Suneva Medical Inc.
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. Specialty European Pharma
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. Sinclair Pharma
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.8. Valeant Pharmaceuticals International Inc.
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.9. LifeCell Corporation
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.10. Dr. Korman Laboratories Ltd.
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
15.1.11. ForeverInject International Holdings Co. Limited
15.1.11.1. Overview
15.1.11.2. Product Portfolio
15.1.11.3. Profitability by Market Segments
15.1.11.4. Sales Footprint
15.1.11.5. Strategy Overview
15.1.11.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Explore Healthcare Insights
View Reports
Non-Hyaluronic Acid Dermal Filler Market
